Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Aton Pharma has launched an expanded, comprehensive distribution program that incorporates sampling, reimbursement assistance and patient education resources, for the dry eye medication Lacrisert.
Subscribe to our email newsletter
In addition to assuring a constant and ready supply to wholesale distributors and providing ordering instructions to all retail pharmacies, Aton Pharma is supporting Lacrisert with a reimbursement assistance help line and other resources.
Lacrisert is a unique preservative-free, once-daily, sustained release prescription insert that helps to retain moisture, stabilize the tear film, and lubricate the eye.
Michael Wells, CEO of Aton Pharma, said: “As part of Aton’s mission to ensure patient access to important therapies, we have established supply chain and commercialization processes to make certain Lacrisert is well-supported and readily available to patients. As a company specializing in essential treatments for under-treated diseases, we are proud to provide a therapeutic option for dry eye with a strong history of effectiveness and safety.”